FDA stops use of antibody drugs that don’t work against omicron

FDA stops use of antibody drugs that don’t work against omicron

Antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections.